Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Pharmacological versus non-pharmacological antipyretic treatments in febrile critically ill adult patients: a systematic review and meta-analysis.

Hammond NE, Boyle M.

Aust Crit Care. 2011 Feb;24(1):4-17. doi: 10.1016/j.aucc.2010.11.002. Epub 2010 Dec 18. Review.

PMID:
21168342
2.

The effect of antipyretic medications on mortality in critically ill patients with infection: a systematic review and meta-analysis.

Jefferies S, Weatherall M, Young P, Eyers S, Perrin KG, Beasley CR.

Crit Care Resusc. 2011 Jun;13(2):125-31. Review.

PMID:
21627583
3.

Antipyretic therapy in febrile critically ill adults: A systematic review and meta-analysis.

Niven DJ, Stelfox HT, Laupland KB.

J Crit Care. 2013 Jun;28(3):303-10. doi: 10.1016/j.jcrc.2012.09.009. Epub 2012 Nov 14. Review.

PMID:
23159136
4.

Comparison of fever treatments in the critically ill: a pilot study.

Henker R, Rogers S, Kramer DJ, Kelso L, Kerr M, Sereika S.

Am J Crit Care. 2001 Jul;10(4):276-80.

PMID:
11432215
5.

Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: a pilot randomized clinical trial.

Niven DJ, Stelfox HT, Léger C, Kubes P, Laupland KB.

J Crit Care. 2013 Jun;28(3):296-302. doi: 10.1016/j.jcrc.2012.08.015. Epub 2012 Oct 24.

PMID:
23102531
6.

Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study.

Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group..

Crit Care. 2012 Feb 28;16(1):R33. doi: 10.1186/cc11211. Erratum in: Crit Care. 2012;16(1):450.

7.

Fever in the critically ill medical patient.

Laupland KB.

Crit Care Med. 2009 Jul;37(7 Suppl):S273-8. doi: 10.1097/CCM.0b013e3181aa6117. Review.

PMID:
19535958
8.

Cooling by convection vs cooling by conduction for treatment of fever in critically ill adults.

Creechan T, Vollman K, Kravutske ME.

Am J Crit Care. 2001 Jan;10(1):52-9.

PMID:
11153185
9.

Clinical trial of a novel surface cooling system for fever control in neurocritical care patients.

Mayer SA, Kowalski RG, Presciutti M, Ostapkovich ND, McGann E, Fitzsimmons BF, Yavagal DR, Du YE, Naidech AM, Janjua NA, Claassen J, Kreiter KT, Parra A, Commichau C.

Crit Care Med. 2004 Dec;32(12):2508-15.

PMID:
15599159
10.

Fever effects and treatment in critical care: literature review.

Kiekkas P, Aretha D, Bakalis N, Karpouhtsi I, Marneras C, Baltopoulos GI.

Aust Crit Care. 2013 Aug;26(3):130-5. doi: 10.1016/j.aucc.2012.10.004. Epub 2012 Nov 28. Review.

PMID:
23199670
11.

Does the use of antipyretics in children who have acute infections prolong febrile illness? A systematic review and meta-analysis.

Purssell E, While AE.

J Pediatr. 2013 Sep;163(3):822-7.e1-2. doi: 10.1016/j.jpeds.2013.03.069. Epub 2013 May 8. Review.

PMID:
23664629
12.

Standardized antipyretic treatment in stroke: a pilot study.

Kallmünzer B, Krause C, Pauli E, Beck A, Breuer L, Köhrmann M, Kollmar R.

Cerebrovasc Dis. 2011;31(4):382-9. doi: 10.1159/000321733. Epub 2011 Jan 22.

PMID:
21266804
13.

Physical antipyresis in critically ill adults.

Kiekkas BP, Brokalaki H, Theodorakopoulou G, Baltopoulos GI.

Am J Nurs. 2008 Jul;108(7):40-9; quiz 50. doi: 10.1097/01.NAJ.0000325812.77380.02. Review.

PMID:
18580126
14.

Should we treat fever in critically ill patients? A summary of the current evidence from three randomized controlled trials.

Serpa Neto A, Pereira VG, Colombo G, Scarin FC, Pessoa CM, Rocha LL.

Einstein (Sao Paulo). 2014 Oct-Dec;12(4):518-23. doi: 10.1590/S1679-45082014RW2785. Epub 2014 Nov 18. Review. English, Portuguese.

15.

Effect of intravenous propacetamol on blood pressure in febrile critically ill patients.

Hersch M, Raveh D, Izbicki G.

Pharmacotherapy. 2008 Oct;28(10):1205-10. doi: 10.1592/phco.28.10.1205.

PMID:
18823215
16.

Effect of cooling on oxygen consumption in febrile critically ill patients.

Manthous CA, Hall JB, Olson D, Singh M, Chatila W, Pohlman A, Kushner R, Schmidt GA, Wood LD.

Am J Respir Crit Care Med. 1995 Jan;151(1):10-4.

PMID:
7812538
17.

Symptomatic intravenous antipyretic therapy: efficacy of metamizol, diclofenac, and propacetamol.

Oborilová A, Mayer J, Pospísil Z, Korístek Z.

J Pain Symptom Manage. 2002 Dec;24(6):608-15.

PMID:
12551812
18.

Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections.

Jefferies S, Weatherall M, Young P, Eyers S, Beasley R.

Postgrad Med J. 2012 Jan;88(1035):21-7. doi: 10.1136/postgradmedj-2011-130217. Epub 2011 Nov 25. Review.

PMID:
22121249
19.

Peak fever: helpful or harmful?

Kiekkas P.

Heart Lung. 2011 May-Jun;40(3):272-3. doi: 10.1016/j.hrtlng.2010.10.003. Epub 2011 Mar 2. No abstract available.

PMID:
21367454
20.

Fever management in SAH.

Scaravilli V, Tinchero G, Citerio G; Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage..

Neurocrit Care. 2011 Sep;15(2):287-94. doi: 10.1007/s12028-011-9588-6. Review.

PMID:
21755388

Supplemental Content

Support Center